People: Luminex Corp (LMNX.O)

Summary

Name	Age	Since	Current Position
G. Walter Loewenbaum	68	2002	Independent Chairman of the Board
Patrick Balthrop	56	2004	President, Chief Executive Officer, Director
Harriss Currie	51	2002	Chief Financial Officer, Vice President - Finance, Treasurer
Jeremy Bridge-Cook	44	2009	Senior Vice President - Research and Development
Michael Pintek	44	2009	Senior Vice President - Operations
Russell Bradley	48	2005	Vice President - Business Development and Strategic Planning
David Reiter	46	2003	Vice President, General Counsel, Corporate Secretary
Timothy Dehne	47	2012	Vice President - Global Marketing
Robert Cresci	69	1996	Independent Director
Thomas Erickson	55	2004	Independent Director
Fred Goad	72	1997	Independent Director
Jay Johnston	70	2005	Independent Director
Jim Kever	60	1996	Independent Director
Kevin McNamara	57	2003	Independent Director
Edward Ogunro	60	2009	Independent Director

» Insider Trading

Biographies

Name	Description
G. Walter Loewenbaum	Mr. G. Walter Loewenbaum, II, is Independent Chairman of the Board of Luminex Corp. since September 2002. He served as Vice Chairman of the Board of Directors from April 1998 until January 2000. Mr. Loewenbaum also has served as chairman of the board of directors of 3D Systems since September 1999, and was previously chairman of the board of directors of Envoy. He holds a B.A. from the University of North Carolina.
Patrick Balthrop	Mr. Patrick J. Balthrop, Sr., is President, Chief Executive Officer, Director of Luminex Corp. Mr. Balthrop joined Luminex in May 2004 as President and Chief Executive Officer and has served as a member of the Board of Directors since September 2004. He served as president of Fisher Healthcare, a Fisher Scientific International company, a manufacturer and supplier of products and services principally to the scientific and laboratory markets from 2002 to May 2004. Prior to Fisher Scientific International, Mr. Balthrop served in a number of leadership positions for over 20 years with Abbott primarily in Abbott's Diagnostics Division. Mr. Balthrop's most recent positions at Abbott were as head of worldwide commercial diagnostics operations and as head of Abbott Vascular. Mr. Balthrop holds an M.B.A. from the Kellogg Graduate School of Management of Northwestern University, and a B.S. in Biology from Spring Hill College.
Harriss Currie	Mr. Harriss T. Currie is Chief Financial Officer, Vice President - Finance, Treasurer of Luminex Corp., since October 15, 2002. Since joining Luminex in November of 1998, Mr. Currie previously served in the capacities of Controller and Treasurer. Prior to joining the company, he was employed as the chief financial officer, secretary and treasurer of SpectraCell Laboratories from 1993 to 1998 where he also served as vice president of finance for two subsidiary companies. Mr. Currie earned his B.B.A. from Southwestern University and his M.B.A. in Finance and Marketing from The University of Texas at Austin. Prior to returning to graduate school for his M.B.A., Mr. Currie was a certified public accountant with Deloitte & Touche LLP.
Jeremy Bridge-Cook	Dr. Jeremy Bridge-Cook, Ph.D. is Senior Vice President - Research and Development of Luminex Corp., since June 2009. Dr. Bridge-Cook joined Luminex in March 2007 as Vice President of Luminex Molecular Diagnostics. Previously, Dr. Bridge-Cook served as senior vice president, corporate development of Tm Bioscience. Dr. Bridge-Cook joined Tm Bioscience in July 2000 as director of business development and served in various capacities thereafter, including vice president of business development, vice president of marketing and business development, and finally senior vice president, corporate development. Prior to joining Tm Biosciences, Dr. Bridge-Cook worked for three years as an investment analyst at MDS Capital Corp. and University Medical Discoveries Inc. Dr. Bridge-Cook has a Ph.D. in Immunology from the University of Toronto and a B.Sc. in Biology from McMaster University.
Michael Pintek	Mr. Michael F. Pintek is Senior Vice President - Operations of Luminex Corp., since July 2009. He joined Luminex from Roche Molecular Systems, Inc., a subsidiary of Roche Diagnostics Corporation, where he held several positions of increasing responsibility since 2001, most recently as Vice President and General Manager, Blood Screening at Roche. Prior to Roche Molecular Systems, his experience includes a number of leadership positions with Ventana Medical Systems and Abbott Laboratories’ Diagnostics Division. Mr. Pintek holds a B.S. in Business Administration from Central Michigan University.
Russell Bradley	Mr. Russell W. Bradley is Vice President - Business Development and Strategic Planning of Luminex Corp., since May 23, 2005. Previously, Mr. Bradley spent 17 years at Beckman Coulter, Inc., a manufacturer of biomedical testing systems and products, where he served in various roles of increasing responsibility and most recently as the director of the Beckman Coulter CARES initiative, involved in the company’s clinical HIV monitoring business in developing regions around the globe. During his tenure at Beckman Coulter, Mr. Bradley was involved in the evaluation, market assessment and commercial launch of multiple life science technologies and applications. Mr. Bradley holds a B.Sc. in Immunology and Biochemistry from Monash University, Melbourne, Australia.
David Reiter	Mr. David S. Reiter is Vice President, General Counsel, Corporate Secretary of Luminex Corp., since October 2003. Prior to becoming General Counsel, Mr. Reiter was in private practice with the firm of Phillips & Reiter, PLLC, which provides outsourced general counsel services for technology companies. Before co-founding the firm, Mr. Reiter was vice president and general counsel for 724 Solutions Inc., a provider of mobile commerce software solutions and applications. Earlier in his career, Mr. Reiter served as senior counsel for Compaq Computer Corporation, supporting the Worldwide Sales & Services, Supply Chain Management and Consumer Products Group. Mr. Reiter is a graduate of the University of Southern California (Juris Doctorate/Master of International Relations), University of Sheffield, UK (M.B.A.) and the University of Notre Dame (B.A.) in Government. Mr. Reiter is a member of the Texas Bar and the American Bar Association.
Timothy Dehne	Mr. Timothy R. Dehne is Vice President - Global Marketing of Luminex Corp. Mr. Dehne joined Luminex Corporation as Vice President of Systems Research and Development in July 2009 and currently serves as the Vice President of Global Marketing for the Company. Mr. Dehne spent over 21 years at National Instruments where he held many leadership positions most recently as Senior Vice President, Research and Development from 2003 through 2008. Mr. Dehne is an accomplished executive in engineering, product development, and product strategy with experience in the technology sector. During his tenure at National Instruments his executive responsibilities included positions in research and development, marketing, and strategic marketing. Mr. Dehne holds a B.S. in Electrical Engineering from Rice University and serves on the Board of Directors for both Cirrus Logic, Inc. and privately held Asset Intertech Inc.
Robert Cresci	Mr. Robert J. Cresci is an Independent Director of Luminex Corp., since December 1996. He has been a Managing Director of Pecks Management Partners Ltd., an investment management firm, since September 1990. Mr. Cresci currently serves on the boards of directors of j2 Global Communications, Inc., a provider of outsourced, value-added messaging and communications services and OFS Capital Corporation, a business development company. Within the past five years, Mr. Cresci has served on the board of directors of Sepracor Inc., a research-based pharmaceutical company, and SeraCare Life Sciences, Inc., a provider of a broad scope of biological products and services. Mr. Cresci holds an undergraduate degree in Engineering from the United States Military Academy at West Point and holds a M.B.A. in Finance from the Columbia University Graduate School of Business.
Thomas Erickson	Mr. Thomas W. Erickson is an Independent Director of Luminex Corp., since May 2004. He is currently chairman of the board of Western Dental Services, Inc., a dental practice management company, and Inmar, Inc., a reverse logistics and revenue recovery company. Previously, he served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm, chairman and interim president of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of PATHCare, Inc., an operator of long term care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim president and chief executive officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals, and interim president and chief executive officer and director of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust. Mr. Erickson was also co-founder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Earlier in his career, he held several management positions at American Hospital Supply Corporation. Mr. Erickson currently serves on the board of directors of American Renal Holdings, Inc., a national provider of kidney dialysis services. Mr. Erickson holds a Bachelors degree from University of Iowa and an M.B.A. from Southern Methodist University.
Fred Goad	Mr. Fred C. Goad, Jr., is an Independent Director of Luminex Corp., since September 1997. Since August 2001, he has been a member in Voyent Partners, L.L.C. (“Voyent”), a private investment company. Mr. Goad served as co-chief executive officer of the transaction services division of WebMD Corporation (“WebMD”), a provider of healthcare transaction, information and technology services, from June 2000 through March 2001. From March 1999 through May 2000, Mr. Goad served as senior advisor to the office of the president of the transaction services division of Quintiles Transnational Corporation (“Quintiles”), a contract research company providing a wide range of clinical research services for biotech and pharmaceutical clients. Mr. Goad served as co-chief executive officer and chairman of Envoy Corporation (“Envoy”) from June 1996 until Envoy was acquired by Quintiles in March 1999. From 1985 to June 1996, Mr. Goad served as president and chief executive officer of Envoy, a provider of electronic transaction processing services for the healthcare industry. Within the past five years, Mr. Goad has served on the board of directors of Emageon Inc., a provider of information technology systems for hospitals, healthcare networks and imaging facilities, until its sale in 2008, Performance Food Group Company, a food service distributor, and on the boards of directors of several private companies. Mr. Goad holds a B.S. in business from the University of Virginia.
Jay Johnston	Mr. Jay B. Johnston is an Independent Director of Luminex Corp., since February 2005. Mr. Johnston currently serves as chairman of QuesTek Innovations, LLC, a privately-held company that designs and markets high tech materials, a position he has held since August 2001. From 1975-1999, he held numerous positions at Abbott Laboratories ("Abbott"), a global, broad-based health care company, most recently as corporate vice president for diagnostic assays and systems. He held numerous other positions with Abbott, including president of Dainabot Co. Ltd. and vice president Asia Pacific. Mr. Johnston has experience in general management, product development, technology management, strategic marketing and business development. He holds an M.B.A. in General Management from the Amos Tuck School of Business Administration and a B.A. degree in Public Administration from Dartmouth College.
Jim Kever	Mr. Jim D. Kever is an Independent Director of Luminex Corp., since December 1996. He has been a member in Voyent since August 2001. Mr. Kever served as co-chief executive officer of the transaction services division of WebMD from June 2000 to March 2001. From March 1999 through May 2000, Mr. Kever served as chief executive officer of the transaction services division of Quintiles. From August 1995 through March 1999, Mr. Kever was the president and co-chief executive officer of Envoy. Mr. Kever serves on the boards of directors of 3D Systems Corporation ("3D Systems"), a provider of 3-D printing, rapid prototyping and manufacturing solutions and Tyson Foods, Inc. ("Tyson"), a food processing company. Within the past five years, Mr. Kever has served on the board of directors of ACI Worldwide, Inc., a global provider of electronic payments solutions for financial institutions. Mr. Kever holds a B.S. in business administration from the University of Arkansas and a J.D. from the Vanderbilt University School of Law.
Kevin McNamara	Mr. Kevin M. McNamara is an Independent Director of Luminex Corp., since May 2003. In addition, he provided financial and strategic consulting services to the Company from October 2001 through December 2002. Mr. McNamara served as executive vice president, chief financial officer and treasurer of HealthSpring, Inc., a managed care company, from April 2005 through May 2009. Mr. McNamara also served as non-executive chairman from April 2005 through January 2006 of MedAvant Healthcare Solutions (f/k/a ProxyMed, Inc.), a provider of automated healthcare business and cost containment solutions for financial, administrative and clinical transactions in the healthcare payments marketplace, and served as interim chief executive officer and as a director of ProxyMed, Inc. from December 2004 through June 2005. Mr. McNamara previously served as chief financial officer and a director of HCCA International, Inc., a healthcare management and recruitment company from October 2002 to April 2005. Mr. McNamara currently serves on the board of directors of Tyson. Within the past five years, Mr. McNamara has served on the board of directors of COMSYS IT Partners, Inc. (f/k/a Personnel Group of America, Inc.), an information technology staffing and solutions provider. Mr. McNamara is a Certified Public Accountant (inactive) and holds a B.S. in Accounting from Virginia Commonwealth University and a M.B.A. from the University of Richmond.
Edward Ogunro	Dr. Edward A. Ogunro, Ph.D., is an Independent Director of Luminex Corp., since May 2009. Dr. Ogunro served as senior vice president, R&D and medical affairs and chief scientific officer at Hospira Inc., a global specialty pharmaceutical and medication delivery company, from April 2004 until December 2007. Prior to Abbott's spin-off of Hospira in 2004, Dr. Ogunro served in a number of leadership positions for over 20 years with Abbott, primarily in Abbott's Diagnostics Division, and most recently served as corporate vice president, R&D, medical and regulatory affairs in Abbott's Hospital Products Division. He held numerous other positions with Abbott, including program director for AxSym, analyzers in the diagnostic industry, and divisional vice president for Abbott's Immunodiagnostics and Chemistry R&D Organization. Dr. Ogunro serves on the board of directors of the Myeloproliferative Neoplasms Research Foundation (a not for profit organization). Within the past five years, Dr. Ogunro served on the board of directors of Applied NeuroSolutions, Inc., a company focused on the development of an integrated portfolio of products for the treatment and diagnosis of Alzheimer's disease. Previously, Dr. Ogunro pursued postdoctoral studies and served as an assistant professor at Northwestern University Medical School in Chicago from 1977 to 1982. Dr. Ogunro holds a B.S. in Physiology and Biochemistry from Reading University and a Ph.D. in Biochemistry from London University.

Basic Compensation

Name	Fiscal Year Total
G. Walter Loewenbaum	--
Patrick Balthrop	3,214,480
Harriss Currie	1,011,050
Jeremy Bridge-Cook	866,265
Michael Pintek	811,063
Russell Bradley	802,144
David Reiter	666,066
Timothy Dehne	--
Robert Cresci	--
Thomas Erickson	255,724
Fred Goad	--
Jay Johnston	--
Jim Kever	--
Kevin McNamara	--
Edward Ogunro	--

As Of 30 Dec 2012

Options Compensation

Name	Options	Value
G. Walter Loewenbaum	0	0
Patrick Balthrop	550,000	1,157,369
Harriss Currie	304,000	2,291,080
Jeremy Bridge-Cook	0	0
Michael Pintek	0	0
Russell Bradley	0	0
David Reiter	174,000	706,300
Timothy Dehne	0	0
Robert Cresci	0	0
Thomas Erickson	262,500	633,425
Fred Goad	0	0
Jay Johnston	0	0
Jim Kever	0	0
Kevin McNamara	0	0
Edward Ogunro	0	0

Insider Trading

Name	Shares Traded	Price
LOEWENBAUM GEORGE WALTER II	19,500	$18.07
LOEWENBAUM GEORGE WALTER II	20,000	$18.57
REITER DAVID S	495	$18.37
BRIDGE COOK JEREMY K	919	$18.37
BRADLEY RUSSELL W	495	$18.37
BALTHROP PATRICK J SR	2,584	$18.37
CURRIE HARRISS T	495	$18.37
LOEWENBAUM GEORGE WALTER II	19,000	$18.13
REITER DAVID S	10,000	$18.26
LOEWENBAUM GEORGE WALTER II	11,000	$17.20
LOEWENBAUM GEORGE WALTER II	17,300	$17.22
LOEWENBAUM GEORGE WALTER II	54,635	$17.20
LOEWENBAUM GEORGE WALTER II	10,300	$17.02
LOEWENBAUM GEORGE WALTER II	20,000	$17.09
LOEWENBAUM GEORGE WALTER II	4,765	$16.74
DEHNE TIMOTHY R	547	$16.86
BRIDGE COOK JEREMY K	1,016	$16.86
BRADLEY RUSSELL W	586	$16.86
REITER DAVID S	547	$16.86
CURRIE HARRISS T	547	$16.86
PINTEK MICHAEL F	547	$16.86
BALTHROP PATRICK J SR	2,094	$16.86
BRIDGE COOK JEREMY K	3,881	$17.43
PINTEK MICHAEL F	1,162	$17.43
BALTHROP PATRICK J SR	4,782	$17.43

» Full list on Insider Trading

People: Luminex Corp (LMNX.O)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: